Strides Pharma gets USFDA nod to market generic headache drug

The product, which will be marketed by Singapore-based Strides Pharma Inc in the US market, is a generic version of Teva's Fioricet with Codeine capsules, it added.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2ZaKh6X
via IFTTT

0 comments:

Post a Comment